Exercise Intolerance: What Could Be Causing It

What Exercise Intolerance Actually Means

Exercise intolerance is the inability to perform physical activity at a level expected for a person's age, sex, and baseline fitness. It goes beyond normal fatigue. Patients describe hitting a wall during activities that previously felt manageable, such as climbing stairs, walking at moderate pace, or completing a routine workout.

The physiology involves a chain: the lungs absorb oxygen, the heart pumps oxygenated blood, hemoglobin carries it, and the mitochondria inside muscle cells convert it to ATP. A failure anywhere along this oxygen cascade produces exercise intolerance. The Fick equation (VO2 = cardiac output × arteriovenous oxygen difference) captures this neatly. Reduced cardiac output, impaired oxygen extraction, or both will lower VO2max 1.

Prevalence data suggest that exercise intolerance as a presenting complaint appears in approximately 18-30% of patients visiting primary care for fatigue or reduced functional capacity 2. The differential is broad. That breadth is exactly why a systematic approach matters.

Cardiac Causes: The First Priority to Rule Out

Heart disease is the most dangerous and most common cause of pathological exercise intolerance. Cardiac limitation should be excluded early in any workup because missing it carries the highest risk of adverse outcomes, including sudden cardiac death.

Heart failure with preserved ejection fraction (HFpEF) is a particularly common and under-recognized culprit. A 2019 analysis in the Journal of the American College of Cardiology found that among patients referred for unexplained dyspnea on exertion, 37% met criteria for HFpEF when invasive hemodynamics were measured during exercise 3. The resting echocardiogram often looks normal. Only exercise provocation reveals the elevated filling pressures.

Coronary artery disease limits blood supply to the myocardium under stress. Valvular heart disease (particularly aortic stenosis and mitral regurgitation) restricts forward flow. Hypertrophic cardiomyopathy causes dynamic outflow obstruction that worsens with exertion.

Chronotropic incompetence, the inability to raise heart rate appropriately during exercise, affects 20-40% of patients with heart failure and is independently associated with reduced peak VO2 4. Dr. Ross Arena, a leading cardiopulmonary rehabilitation researcher, has stated: "Chronotropic incompetence is one of the most underappreciated contributors to functional limitation in both heart failure and general deconditioning. It should be assessed in every CPET interpretation" 4.

Cardiac screening typically begins with an ECG, echocardiogram, and BNP/NT-proBNP levels. If suspicion remains high, stress testing or CPET provides definitive data.

Pulmonary Conditions That Limit Exertion

When the lungs cannot deliver adequate oxygen or expel carbon dioxide efficiently, exercise capacity drops. The pattern on CPET differs from cardiac limitation: patients hit a ventilatory ceiling rather than a heart rate ceiling.

COPD is the most prevalent pulmonary cause. Dynamic hyperinflation during exercise traps air, flattens the diaphragm, and limits tidal volume expansion. Even in mild COPD (GOLD stage I), exercise capacity measured by 6-minute walk distance is reduced by an average of 40 meters compared to age-matched controls 5.

Exercise-induced bronchoconstriction (EIB) affects 10-15% of the general population and up to 90% of patients with diagnosed asthma 6. Symptoms typically peak 5-10 minutes after exercise cessation. A eucapnic voluntary hyperventilation (EVH) test or exercise challenge confirms the diagnosis. Many patients with EIB go years without recognition because they attribute their symptoms to poor fitness.

Interstitial lung disease and pulmonary hypertension cause exertional oxygen desaturation. Any patient whose SpO2 drops below 88% during a supervised walk test warrants urgent pulmonary evaluation. The 2022 European Society of Cardiology/European Respiratory Society guidelines for pulmonary hypertension emphasize that unexplained exercise intolerance with a mean diagnostic delay of 2-3 years remains a significant problem 7.

Anemia and Iron Deficiency

This is the most correctable cause. Hemoglobin carries oxygen to working muscles. When hemoglobin falls, oxygen delivery falls proportionally.

A hemoglobin of 10 g/dL (vs. a normal 14 g/dL in men) represents a roughly 28% reduction in oxygen-carrying capacity. The World Health Organization defines anemia as hemoglobin <13 g/dL in men and <12 g/dL in women 8.

Iron deficiency without anemia is equally important and frequently overlooked. A ferritin below 30 ng/mL impairs oxidative enzyme function in skeletal muscle independent of hemoglobin level. A randomized trial of 198 non-anemic women with ferritin <50 ng/mL showed that intravenous iron (ferric carboxymaltose 1 to 000 mg) improved submaximal exercise endurance by 2.4 minutes on cycle ergometry compared to placebo (P<0.001) 9.

A basic workup includes CBC, ferritin, iron studies, and reticulocyte count. Treatment depends on the underlying cause: oral iron for dietary deficiency, IV iron for malabsorption or inflammatory states, and investigation for GI blood loss in any male or postmenopausal female with new iron deficiency.

Hormonal Deficiencies

Several endocrine disorders directly impair exercise tolerance. They are often missed because symptoms develop gradually.

Hypothyroidism reduces cardiac output, impairs skeletal muscle oxidative capacity, and blunts ventilatory drive. A TSH above 10 mIU/L is associated with a mean reduction in VO2max of 15-20% 10. Even subclinical hypothyroidism (TSH 4.5-10 mIU/L with normal free T4) correlates with reduced exercise capacity in some studies, though treatment benefit in this group remains debated.

Testosterone deficiency affects muscle mass, mitochondrial density, and erythropoiesis. Men with total testosterone below 300 ng/dL show measurable reductions in grip strength, lean body mass, and peak exercise performance. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older with testosterone <275 ng/dL, demonstrated that one year of testosterone gel improved 6-minute walk distance by a mean of 33 meters compared to placebo 11.

Adrenal insufficiency (primary or secondary) causes exercise intolerance through cortisol deficiency, which impairs gluconeogenesis and vascular tone. Patients may report profound fatigue, orthostatic symptoms, and an inability to sustain effort. Morning cortisol <3 µg/dL is highly suggestive; an ACTH stimulation test confirms the diagnosis.

Growth hormone deficiency in adults reduces lean mass, increases fat mass, and lowers VO2max. Replacement therapy in confirmed GH-deficient adults has been shown to improve exercise capacity by 10-15% over 6-12 months 12.

The Endocrine Society's 2018 clinical practice guideline recommends screening for testosterone deficiency in men presenting with "unexplained fatigue, reduced physical performance, or loss of muscle mass" 13.

Deconditioning and Prolonged Inactivity

Deconditioning is simultaneously the most common cause and the most frequently dismissed. Patients and clinicians alike tend to assume "something else must be going on." Often, inactivity itself is the primary driver.

Bed rest studies from NASA and the University of Texas Southwestern demonstrate that VO2max declines approximately 0.5% per day during complete bed rest, with a 26% reduction after 20 days 14. After prolonged illness, surgery, or simply months of sedentary behavior, the cardiovascular and musculoskeletal systems lose conditioning in predictable, measurable ways: stroke volume decreases, peripheral vascular resistance increases, and skeletal muscle capillary density drops.

Dr. Benjamin Levine, Director of the Institute for Exercise and Environmental Medicine at UT Southwestern, has noted: "The cardiovascular response to deconditioning is remarkably similar to the response to aging. Both produce a stiff, small heart with reduced compliance. The difference is that deconditioning is reversible" 14.

Reconditioning follows a dose-response curve. For most patients, a structured progressive exercise program over 8-12 weeks restores 70-80% of lost aerobic capacity. The key is starting below symptom threshold and titrating upward systematically.

Medications That Impair Exercise Capacity

Several commonly prescribed drug classes directly reduce exercise performance through known pharmacological mechanisms.

Beta-blockers limit peak heart rate by 20-30%, which directly reduces maximal cardiac output. Atenolol, metoprolol, and propranolol all blunt the chronotropic response to exercise. In patients taking beta-blockers for hypertension (rather than heart failure or post-MI), exercise intolerance is one of the leading reasons for medication discontinuation 15.

Statins cause myalgia and occasionally true myopathy. A meta-analysis of 176 statin trials found that muscle symptoms occurred in 7-29% of patients depending on the definition used 16. Coenzyme Q10 depletion has been proposed as a mechanism, though evidence for supplementation remains mixed.

Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin) carry FDA black-box warnings for tendinopathy and can cause persistent fatigue and exercise intolerance that outlasts the treatment course by weeks.

GLP-1 receptor agonists (semaglutide, tirzepatide) may reduce exercise tolerance indirectly through caloric restriction, nausea-driven reduced intake, and lean mass loss during rapid weight reduction. The STEP-1 trial (N=1,961) reported that semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks, of which approximately 39% was lean mass 17. Patients on these medications who experience new exercise intolerance should have protein intake optimized (1.2-1.6 g/kg/day) and consider concurrent resistance training.

SSRIs and SNRIs can cause fatigue, sedation, and increased perceived exertion. Paroxetine and duloxetine tend to produce more exercise-related complaints than sertraline or escitalopram.

Any patient presenting with new exercise intolerance should have a complete medication reconciliation. Drug timing adjustments or substitutions often resolve the issue without additional workup.

Mitochondrial and Metabolic Myopathies

When standard cardiac, pulmonary, and hematologic evaluations are unremarkable, metabolic muscle disease enters the differential. These conditions are uncommon individually but collectively affect an estimated 1 in 4,300 adults 18.

McArdle disease (glycogen storage disease type V) presents with exercise intolerance, early fatigue, and myalgia during the first minutes of exertion, followed by a characteristic "second wind" phenomenon as the muscles switch to fatty acid oxidation. Diagnosis requires forearm ischemic exercise testing or genetic analysis of the PYGM gene.

Mitochondrial myopathies cause exercise intolerance through impaired oxidative phosphorylation. Hallmarks include disproportionate lactic acidosis at low workloads and a low anaerobic threshold on CPET. Muscle biopsy showing ragged red fibers remains the histologic gold standard, though next-generation sequencing panels have largely replaced biopsy as a first-line diagnostic approach.

Carnitine deficiency impairs long-chain fatty acid transport into mitochondria. Serum free carnitine <20 µmol/L supports the diagnosis. Supplementation with L-carnitine 1-3 g/day can substantially improve exercise tolerance in confirmed deficiency.

Post-Infectious and Autonomic Causes

Exercise intolerance is a defining feature of post-infectious syndromes. Post-COVID condition (long COVID) affects an estimated 10-30% of non-hospitalized COVID-19 survivors, and exercise intolerance ranks among the top three reported symptoms alongside fatigue and cognitive dysfunction 19.

Postural orthostatic tachycardia syndrome (POTS) produces exercise intolerance through excessive heart rate elevation, reduced stroke volume in the upright position, and blood pooling in the lower extremities. Heart rate increase of 30 bpm or more (or absolute rate exceeding 120 bpm) within 10 minutes of standing, without orthostatic hypotension, meets diagnostic criteria. A graded recumbent exercise program (starting with rowing or recumbent cycling) is first-line therapy and produces clinically meaningful improvement in 53-71% of patients after 3 months 20.

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) involves post-exertional malaise: a characteristic worsening of symptoms 12-72 hours after physical or cognitive exertion that exceeds the patient's energy envelope. The distinction from deconditioning is critical. Graded exercise therapy, which benefits deconditioned patients, may worsen ME/CFS. Pacing strategies (activity management within energy limits) are the recommended approach per 2021 NICE guidelines 21.

The Diagnostic Workup: A Step-by-Step Approach

Evaluation should proceed from broad screening to targeted testing based on clinical suspicion.

Step 1: History and physical. Ask about onset (acute vs. gradual), pattern (constant vs. episodic), associated symptoms (dyspnea, chest pain, palpitations, syncope, myalgia), and medication changes. A cardiac and lung exam, orthostatic vitals, and assessment of muscle bulk provide immediate direction.

Step 2: First-line labs. CBC with differential, comprehensive metabolic panel, TSH, free T4, ferritin, iron studies, BNP or NT-proBNP, and morning cortisol. In men over 40 or symptomatic younger men, add total and free testosterone. CRP and ESR help screen for inflammatory conditions.

Step 3: Cardiopulmonary screening. ECG and echocardiogram for all patients with suspected cardiac involvement. Pulmonary function tests (spirometry, DLCO) when respiratory symptoms are present. Chest imaging if indicated.

Step 4: Cardiopulmonary exercise testing (CPET). The single most informative test for unexplained exercise intolerance. CPET simultaneously measures gas exchange, cardiac response, and ventilatory mechanics during graded exercise. It can differentiate cardiac limitation (low O2 pulse, reduced peak VO2, abnormal blood pressure response), pulmonary limitation (ventilatory reserve <15%, desaturation), peripheral/metabolic limitation (low anaerobic threshold, excessive lactate), and deconditioning (normal responses at low peak work rate) 1.

Step 5: Targeted testing. Based on CPET results and clinical context: right heart catheterization for suspected pulmonary hypertension, exercise echocardiography for HFpEF, genetic testing or muscle biopsy for metabolic myopathy, tilt table testing for POTS.

When to Seek Urgent Evaluation

Most exercise intolerance has a benign, treatable cause. Certain presentations require same-day or emergency evaluation.

Exertional syncope (passing out during exercise) may indicate hypertrophic cardiomyopathy, aortic stenosis, or arrhythmia. Exertional chest pressure with ECG changes warrants immediate cardiac evaluation. New exercise intolerance combined with leg swelling and orthopnea suggests decompensated heart failure. Oxygen saturation dropping below 88% during exertion points to significant pulmonary disease requiring urgent workup 7.

Any patient over 40 with new-onset exercise intolerance and cardiovascular risk factors (diabetes, hypertension, smoking, family history of premature coronary disease) should have cardiac causes excluded before attributing symptoms to deconditioning.

Patients under 30 presenting with exercise intolerance, disproportionate heart rate responses, and recurrent presyncope should be evaluated for inherited cardiac conditions and autonomic disorders. A resting heart rate above 100 bpm warrants thyroid function testing and consideration of tachyarrhythmia.

The simplest screening tool remains the 6-minute walk test: a distance below 350 meters in adults under 65 is abnormal and warrants formal CPET referral.